Filing Flows › CareDx (CDNA) › R&D spending
CareDx (CDNA) R&D spending by quarter
CareDx's R&D spending was $21.3M in Q3 2026 (third quarter 2026), -0.4% from Q1 2026. Over the last 6 quarters it ranged from $16.8M (Q3 2025) to $21.4M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $21.3M | -0.4% | +27% |
| Q1 2026 | $21.4M | +11% | +16% |
| Q4 2025 | $19.3M | +15% | — |
| Q3 2025 | $16.8M | -0.4% | — |
| Q2 2025 | $16.8M | -9% | — |
| Q1 2025 | $18.5M | — | — |
Q3 2026 at a glance
CareDx, Q3 2026: revenue $139M (+39% year over year), operating margin 5.8%, net earnings $19.3M, operating cash flow $12.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is CareDx's R&D spending?
CareDx's R&D spending was $21.3M in Q3 2026 (third quarter 2026), -0.4% from Q1 2026.
How has CareDx's R&D spending changed?
Over the last 6 quarters it ranged from $16.8M (Q3 2025) to $21.4M (Q1 2026).